Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma - sprookjes - yvandenbroek - TriplyDB

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

http://www.wikidata.org/entity/Q28193206

about

sameAs

COX-2: where are we in 2003?--distinction from NSAIDs becoming blurred Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity The safety of rofecoxib Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital Nonsteroidal anti-inflammatory drug-induced reactions and desensitization Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature Angioedema associated with aspirin and rofecoxib Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity Tolerance to etoricoxib in children with nonsteroidal anti-inflammatory drug hypersensitivity Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.Uteroglobin represses allergen-induced inflammatory response by blocking PGD2 receptor-mediated functions Immediate-type allergy to drugs and related compounds: evaluation and management.Pathway-oriented profiling of lipid mediators in macrophages.Tolerance to alternative cyclooxygenase-2 inhibitors in nonsteroidal anti-inflammatory drug hypersensitive patients.Role of aspirin and other nonsteroidal anti-inflammatory drugs in aspirin-exacerbated respiratory disease.COX inhibitors for airway inflammation.Prostanoids receptors signaling in different diseases/cancers progression.Pilot study of the use of Yin Qiao San in children with conventional antipyretic hypersensitivity.Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products.Non-steroidal anti-inflammatory drugs-induced urticaria and angioedema: more research on mechanisms needed.

P2860

Q24804373-7230C0F5-04C1-4735-A19C-A8F6DCB0FE13 Q28165516-BFCDBB42-60B6-40D7-A8E6-999E12D03384 Q28176535-25CB1DFF-5AD7-4B36-B65A-ECFB7D51B022 Q28177036-F84ED97A-46AB-4929-B794-81081D4DA657 Q28209835-9D391598-94E6-4F27-87C3-95DCDF24EE3D Q28210177-BD8BAF8C-22BF-4F1E-8A88-5AA5B1CD95A5 Q28212096-B0700BAF-9A4A-45A5-A664-C699108B2FEA Q28217965-16D51F16-96F7-4231-8254-4CE606968A72 Q35037712-3EDDE097-7132-420A-B787-FF14283F8622 Q35195182-9B8D559D-82B2-48CD-98BD-DCB23219D451 Q36399173-3451BA84-59DF-4713-A102-94C852CCF4B6 Q36406780-7C6B343F-16BD-43FB-BEE5-96EBDF692641 Q36688853-0C5B81CC-0510-4281-B8E9-0037AA4CDD87 Q36992581-748F230C-8AE3-475F-AEFD-3BA8A466E124 Q37754746-15620AA9-BF2F-4F2A-83E4-CA059FC70E83 Q37983125-FDDF10AB-D1C0-4741-95D2-08BD044087AB Q38074716-6493E729-C90D-4085-83C2-10F878AB29FD Q39181145-91C70B48-5B7C-4A8F-B3C8-5EDACE5C940D Q39777516-04AA7725-D8A8-4A3F-BE1A-DB6DD8DF0B94 Q46559672-E7CBACCC-08A0-4542-BE83-D7C94BADFA21

P2860

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

http://www.wikidata.org/entity/Q28193206

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

@ast

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

@en

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

@nl

type

label

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

@ast

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

@en

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

@nl

prefLabel

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

@ast

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

@en

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

@nl

P1433

Q28193206-E966CDF1-FDD8-46A8-AE16-7F541575EB40

P1476

Q28193206-E2F3AA2F-5ED9-4517-A0DF-82F8AD180C97

P2093

Q28193206-2F2D4161-2758-4603-A955-05449AC4E646

Q28193206-3E30BEE7-D615-40C2-928A-2E1EEFFB9ADD

Q28193206-4C41D978-5844-4D14-837A-636C48987731

Q28193206-A6975609-9D06-4932-B01F-B0886CEC3909

Q28193206-B7041DA0-61B6-4854-A557-7B4E2D9C522F

Q28193206-F1D1249E-F1C4-469E-9BFD-7EA60ED233A7

P304

Q28193206-594E1532-E8C3-4169-8F79-920FAE3F87C2

P31

Q28193206-1B30C174-6B62-4528-A03B-120117E7A5DF

P356

Q28193206-ED80E687-DA5C-4FBF-B23C-91AF3EC2A502

P407

Q28193206-5D7AC118-C5C9-4A1E-B685-5B327926E69D

P433

Q28193206-20761F2E-B413-4360-B37E-D48BC659C71C

P478

Q28193206-3CB4216F-3692-4D81-9400-8B4992577249

P50

Q28193206-C83E1077-F6B3-4A93-B10D-D5A1531B2C34

P577

Q28193206-057EEB4A-E0AF-4CE3-A7D1-577AD36C003F

P5875

Q28193206-C2F1DBB2-FEBC-4542-9060-AD5D70AD2A39

P698

Q28193206-EEF78BB3-6BB7-4A8C-A6C4-494A1886CA10

P921

Q28193206-11D1FE3C-1369-4C95-AC12-2155ABE3DE08

Q28193206-70337D6F-7E84-4909-8282-E51AFE0EE267

P356

CHEST.121.6.1812

P1433

P1476

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

@en

P2093

Alberto Iscar

http://www.w3.org/2001/XMLSchema#string

Cristina Martín-García

http://www.w3.org/2001/XMLSchema#string

Encarnación Camacho

http://www.w3.org/2001/XMLSchema#string

Miguel Hinojosa

http://www.w3.org/2001/XMLSchema#string

Pilar Berges

http://www.w3.org/2001/XMLSchema#string

Rosa García-Rodriguez

http://www.w3.org/2001/XMLSchema#string

P304

1812-1817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.121.6.1812

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11309880

http://www.w3.org/2001/XMLSchema#string

P698

12065343

http://www.w3.org/2001/XMLSchema#string

P921